# U-LABA/ICS Effects on Exercise Performance, Indacaterol

> **NCT06067100** · NA · RECRUITING · sponsor: **Morten Hostrup, PhD** · enrollment: 30 (estimated)

## Conditions studied

- Exercise Performance

## Interventions

- **DRUG:** Indacaterol and Mometasonefluroate (low dose)
- **DRUG:** Placebo
- **DRUG:** Indacaterol and Mometasonefluroate (high dose)

## Key facts

- **NCT ID:** NCT06067100
- **Lead sponsor:** Morten Hostrup, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-15
- **Primary completion:** 2026-07-15
- **Final completion:** 2026-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06067100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06067100, "U-LABA/ICS Effects on Exercise Performance, Indacaterol". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06067100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*